Brief: Heidelberg Pharma Announces It Receives With Huadong All Approvals For The Announced Transaction From The Authorities And Plan Capital Measure

Heidelberg Pharma AG

09/05/2022 15:49

May 9 (Reuters) - HEIDELBERG PHARMA AG  HPHA.DE :
    * HEIDELBERG PHARMA AG AND PARTNER HUADONG RECEIVE ALL
APPROVALS
FOR THE ANNOUNCED TRANSACTION FROM THE AUTHORITIES AND PLAN
CAPITAL MEASURE
    * INVESTMENT BY HUADONG IS PLANNED IN AUGUST 2022 TOTALING
EUR 105
MILLION, REPRESENTING 35% OF OUTSTANDING SHARES AFTER
TRANSACTION, CONSISTING OF A RIGHTS ISSUE AND A SHARE TRANSFER.
    * INVESTMENT AGREEMENT WAS SUBJECT TO CERTAIN CLOSING
CONDITIONS
SUCH AS FOREIGN TRADE CLEARANCE
    * THESE CLOSING CONDITIONS ARE NOW FULFILLED. THEREFORE,
HEIDELBERG PHARMA IS PLANNING TO IMPLEMENT RIGHTS ISSUE

Source text for Eikon:  ID:nEQ3hdFjra 
Further company coverage:  HPHA.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))